Coloplast A/S (COLOB:DC) (CLPBY) PT Raised to DKK912 at JPMorgan, Following Earnings
- Technology stocks lead S&P 500, Dow to record highs
- Thermo Fisher Scientific (TMO) to Acquire PPD, Inc. (PPD) for $47.50/sh, $17.4 Billion
- U.S. retail sales post largest gain in 10 months; weekly jobless claims fall
- Dell (DELL) Gains on Spin-Off of its 81% Stake in VMware (VMW), Analysts Bulled-Up as It Could Unlock $20 Per Share of Value for DELL
- Cathie Wood's ARK Buys 750K Shares of Coinbase (COIN), Sells 240K Shares of Tesla (TSLA)
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
JPMorgan analyst David Adlington raised the price target on Coloplast A/S (COLOB:DC) (OTC: CLPBY) to DKK912.00 (from DKK880.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bank of Queensland Ltd. (BOQ:AU) (BKQNY) PT Raised to AUD10 at Credit Suisse
- Pendal Group Ltd (PDL:AU) PT Raised to AUD7.81 at Goldman Sachs
- CIMB Upgrades E-Mart (139480:KS) to Hold
Create E-mail Alert Related CategoriesAnalyst PT Change, Intl Ratings
Related EntitiesJPMorgan, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!